| Particulars |
| Company Name |
Aurobindo Pharma Ltd |
| Face Value |
1 |
| BSE Code |
524804 |
| Year End |
202303 |
| Full Year |
| Equity (Rs in Cr.) |
58.59 |
| B.V. Rs |
318.50 |
| Sales Rs in Cr. |
12,792.28 |
| NP Rs in Cr. |
1,220.43 |
| NP Var% |
-21.00 |
| Div% |
750.00 |
| CPS Rs |
28.30 |
| EPS Rs |
20.80 |
| Traded Value(Rs in Lakhs) |
264.14 |
| 52 Week High |
1,177.00 |
| 52 Week Low |
582.00 |
| Price BSE |
1,153.00 |
| Price NSE |
1,152.00 |
| Market Capital(Rs in Cr.) |
67,541.14 |
| P/C Ratio |
40.80 |
| P/E Ratio |
55.40 |
| Price Vs.BV |
3.62 |
| Latest Quarter |
| Year End |
202312 |
| Sales Rs in Cr. |
2,663.87 |
| NP Rs in Cr. |
623.78 |
| NP Var % |
93.00 |
| Trailing Twelve Months |
| Year End |
202312 |
| Sales |
11,197.53 |
| OPM |
10.11 |
| NP |
1,400.90 |
| NP Var% |
30.76 |
| EPS |
33.56 |
| PE |
34.35 |
|